On the way to colleges: 40,000 doses of opioid-blocker naloxone, the ‘Lazarus drug’

As the U.S. government and health care providers grapple with the exploding rates of opioid abuse across the country, the Clinton Foundation has expanded its partnership with Adapt Pharma, maker of Narcan nasal spray, by donating 40,000 doses of the opioid overdose reversal drug to colleges and universities throughout the United States. Narcan, a brand of the generic drug naloxone, is used for the emergency treatment of known or suspected opioid overdose.